Keywords: antisoma, sees, losses, increase, uk, biopharmaceutical, company
Antisoma sees losses increase in 2005
Article | 27 February 2006
UK biopharmaceutical company Antisoma has reported losses of L8.2 million ($14.2 million) for the six months ended December 31, 2005, up from the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
